Patient-reported outcomes (PROs) in IMmotion150: Atezolizumab (atezo) alone or with bevacizumab (bev) versus sunitinib (sun) in first-line metastatic renal cell carcinoma (mRCC).

Sumanta K.  Pal

Honoraria - Astellas Pharma; Medivation; Novartis

Consulting or Advisory Role - Astellas Pharma; Aveo; Bristol-Myers Squibb; Eisai; Exelixis; Genentech; Ipsen; Myriad Pharmaceuticals; Novartis; Pfizer

Research Funding - Medivation

David F.  McDermott

Consulting or Advisory Role - alkermes; Array BioPharma; Bristol-Myers Squibb; EMD Serono; exelixis; Genentech/Roche; Jounce Therapeutics; Lilly; Merck; Novartis; Peloton Therapeutics; Pfizer; X4 Pharma

Research Funding - alkermes (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); Merck (Inst); Novartis (Inst); Peloton Therapeutics (Inst); Prometheus (Inst)

Other Relationship - Beth Israel Deaconess Medical Center; Various

Michael B.  Atkins

Honoraria - Bristol-Myers Squibb

Consulting or Advisory Role - Acceleron Pharma; Aduro Biotech; Agenus; Array BioPharma; Arrowhead Pharmaceuticals; Boehringer Ingelheim; Bristol-Myers Squibb; Eisai; Exelixis; Genentech; Glactone Pharma; Immunocore; Iovance Biotherapeutics; Merck; Newlink Genetics/Pharmatech; Novartis; Oncolys BioPharma; Pfizer; Surface Oncology; Werewolf Pharma; X4 Pharma

Research Funding - Bristol-Myers Squibb (Inst)

Bernard  Escudier

Honoraria - AVEO; Bristol-Myers Squibb; EUSA Pharma; Pfizer; Roche

Consulting or Advisory Role - AVEO; Bristol-Myers Squibb; Pfizer

Travel, Accommodations, Expenses - Bristol-Myers Squibb; Roche

Brian I.  Rini

Consulting or Advisory Role - AVEO; Bristol-Myers Squibb; Merck; Novartis; Pfizer; Roche/Genentech; synthorx

Research Funding - AstraZeneca/MedImmune (Inst); AVEO (Inst); Bristol-Myers Squibb (Inst); Merck (Inst); Peloton Therapeutics (Inst); Pfizer (Inst); Roche/Genentech (Inst)

Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck; Pfizer

Robert J.  Motzer

Consulting or Advisory Role - Eisai; Exelixis; Genentech/Roche; Incyte; Lilly; Merck; Novartis; Pfizer

Research Funding - Bristol-Myers Squibb (Inst); Eisai (Inst); Genentech/Roche (Inst); Novartis (Inst); Pfizer (Inst)

Lawrence  Fong

Consulting or Advisory Role - Atreca; BioAtla; Bolt Biotherapeutics; IDEAYA Biosciences; Nutcracker Therapeutics, Inc.; TeneoBio

Research Funding - Abbvie (Inst); Bristol-Myers Squibb (Inst); Janssen Oncology (Inst); Merck (Inst); Roche/Genentech (Inst)

Richard Wayne  Joseph

Consulting or Advisory Role - Bristol-Myers Squibb; Bristol-Myers Squibb; Eisai; Exelixis; Genoptix; Merck (Inst); Nektar; Novartis

Research Funding - Amgen (Inst); Bristol-Myers Squibb; Merck; Roche/Genentech (Inst); X4 Pharma (Inst)

Stephane  Oudard

Honoraria - Astellas Pharma; Bayer; Bristol-Myers Squibb; Eisai; Janssen; Merck; Novartis; Pfizer; Sanofi

Consulting or Advisory Role - Astellas Pharma; Bayer; Bristol-Myers Squibb; Eisai; Janssen; Merck; Novartis; Pfizer; Sanofi

Research Funding - Ipsen; Sanofi

Travel, Accommodations, Expenses - Bayer; Bristol-Myers Squibb; Eisai; Merck; Novartis; Pfizer

Alain  Ravaud

Honoraria - Bristol-Myers Squibb; Ipsen; Novartis; Pfizer

Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Ipsen; Novartis; Pfizer; Roche

Research Funding - Pfizer (Inst)

Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; ipsen; MSD; Novartis; Pfizer; Roche

Sergio  Bracarda

Honoraria - Astellas Pharma; Bristol-Myers Squibb; Janssen Oncology; Roche/Genentech

Consulting or Advisory Role - Bristol-Myers Squibb; Ipsen; Janssen Oncology; MSD Oncology; Pfizer; Roche/Genentech

Travel, Accommodations, Expenses - Astellas Pharma; Exelixis/Ipsen; Ipsen; Novartis; Pfizer; Roche

Cristina  Suarez Rodriguez

Consulting or Advisory Role - Astellas Pharma; Bristol-Myers Squibb; EUSA Pharma; Ipsen; Novartis; Pfizer; Sanofi

Speakers' Bureau - AstraZeneca; Bristol-Myers Squibb; Ipsen; Pfizer; Roche/Genentech

Research Funding - AB Science (Inst); Arog (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); AVEO (Inst); Bayer (Inst); Blueprint Medicines (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Calithera Biosciences (Inst); Clovis Oncology (Inst); Cougar Biotechnology (Inst); Deciphera (Inst); Exelixis (Inst); GlaxoSmithKline (Inst); Incyte (Inst); Janssen Oncology (Inst); Karyopharm Therapeutics (Inst); MedImmune (Inst); Millennium (Inst); Nanobiotix (Inst); Novartis (Inst); Pfizer (Inst); Puma Biotechnology (Inst); Roche/Genentech (Inst); SFJ Pharmaceuticals Group (Inst); Teva (Inst)

Travel, Accommodations, Expenses - Bristol-Myers Squibb; Roche

Elaine Tat  Lam

Consulting or Advisory Role - Astellas Pharma; Calithera Biosciences

Research Funding - Advaxis (Inst); Argos Therapeutics (Inst); Astellas Pharma (Inst); Bristol-Myers Squibb (Inst); Calithera Biosciences (Inst); Constellation Pharmaceuticals (Inst); Exelixis (Inst); Merck (Inst); Peloton Therapeutics (Inst); Pfizer (Inst); Roche/Genentech (Inst)

Travel, Accommodations, Expenses - Constellation Pharmaceuticals

Toni K.  Choueiri

Employment - Dana Farber Cancer Hospital

Leadership - Dana Farber Cancer Hospital; Kidney Cancer Association; NCCN

Honoraria - Alexion Pharmaceuticals; alligent; Analysis Group; ASCO; AstraZeneca; Bayer; Bristol-Myers Squibb; Cerulean Pharma; Clinical Care Options; Corvus Pharmaceuticals; Eisai; EMD Serono; Exelixis; Foundation Medicine; Genentech/Roche; GlaxoSmithKline; Harborside Press; HERON; Ipsen; Kidney Cancer Association; Lancet Oncology; Lilly; Lpath; Merck; Michael J. Hennessy Associates; Navinata Health; NCCN; Novartis; Peloton Therapeutics; Pfizer; PlatformQ Health; Prometheus; Sanofi/Aventis; The New England Journal of Medicine; UpToDate

Consulting or Advisory Role - Alexion Pharmaceuticals; alligent; Analysis Group; ASCO; AstraZeneca; Bayer; Bristol-Myers Squibb; Cerulean Pharma; Clinical Care Options; Corvus Pharmaceuticals; Eisai; EMD Serono; Exelixis; Foundation Medicine; GlaxoSmithKline; Harborside Press; HERON; Ipsen; Kidney Cancer Association; Lancet Oncology; Lilly; Lpath; Merck; Michael J. Hennessy Associates; Navinata Health; NCCN; Novartis; Peloton Therapeutics; Pfizer; PlatformQ Health; Prometheus; Roche/Genentech; Sanofi/Aventis; The New England Journal of Medicine; UpToDate

Research Funding - Agensys (Inst); Analysis Group (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Calithera Biosciences (Inst); Celldex (Inst); Cerulean Pharma (Inst); Corvus Pharmaceuticals (Inst); Eisai (Inst); Exelixis (Inst); Foundation Medicine (Inst); GlaxoSmithKline (Inst); Ipsen (Inst); Merck (Inst); Novartis (Inst); Peloton Therapeutics (Inst); Pfizer (Inst); Prometheus (Inst); Roche (Inst); Roche/Genentech (Inst); Seattle Genetics/Astellas (Inst); Takeda (Inst); TRACON Pharma (Inst)

Other Relationship - Medical writing and editorial assistance support may have been funded by Communications companies funded by pharmaceutical companies such as ClinicalThinking, Health Interactions, Envision Pharma Group, Fishawack Group of Companies, Parexel

Beiying  Ding

Employment - Genentech/Roche

Stock and Other Ownership Interests  - Genentech/Roche

Caroleen  Quach

No Relationships to Disclose

Kenji  Hashimoto

Employment - Chugai Pharma Europe; Roche

Stock and Other Ownership Interests  - Roche

Christina  Schiff

Employment - Genentech/Roche; Genentech/Roche (I)

Stock and Other Ownership Interests  - Genentech/Roche; Genentech/Roche (I)

Patents, Royalties, Other Intellectual Property - Genentech/Roche

Elisabeth  Piault

Employment - Medaptive Health

Stock and Other Ownership Interests  - Medaptive Health

Travel, Accommodations, Expenses - Genentech

Thomas  Powles

Honoraria - AstraZeneca; Bristol-Myers Squibb; MERCK; Novartis; Pfizer; Roche/Genentech

Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Genentech/Roche; Incyte; Ipsen; Merck; Novartis; Novartis; Pfizer; Seagen

Research Funding - AstraZeneca/MedImmune; Roche/Genentech

Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; MSD; Novartis/Ipsen; Pfizer; Roche/Genentech